In patients with obesity, intracellular targets such as the deacetylating enzyme sirtuin-1 (SIRT-1), adenosine monophosphate-activated protein kinase (AMPK), and peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) are altered [67]. Here, PPARGC1A is linked to obesity disorder.